Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of the mammoth $1.7 trillion, bipartisan government appropriations bill signed in
The World Health Organization (WHO) recently issued a Medical Product Alert after four substandard products were identified in The Gambia, which may be linked to t
How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
Proper storage and transportation of finished drug products is critical to activities in an integrated supply chain.
An all-too-familiar experience in recent years, medicines supply chain disruptions can arise from many factors, including pandemics like COVID-19, natural disasters, and geopolitical events like those taking place right now in Eastern Europe.